Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

NCT00946946 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Azathioprine
DRUG: Mesalazine
DRUG: Azathioprine placebo
DRUG: Mesalazine placebo

Sponsor

Dr. Falk Pharma GmbH